Journal of Thrombosis and Haemostasis
Publisher: Elsevier · ISSN 1538-7836 · 85 articles
- Suspicion-based screening for occult malignancy in lower-extremity venous thrombosis: a real-world cohort study
- Association of fibrinogen γ’ with recurrent thrombosis: a nested case-control study
- Carbon tetrachloride (CCl4)-induced liver injury activates hepatocyte-independent tissue factor-driven coagulation
- Plasma levels of adiponectin and risk of future incident venous thromboembolism
- TQB3473, a novel spleen tyrosine kinase inhibitor for primary immune thrombocytopenia: a single-arm, open-label, multicenter phase 1 study
- RNA sequencing indicates distinct platelet transcriptomic changes in immune thrombocytopenia
- Immunogenic risk assessment of porcine, bovine, and ovine heparins for diversifying the global heparin supply
- Rab31 promotes platelet activation and arterial thrombosis via ERK–PLCβ3 signaling and regulation of CD151
- A historical review of the biological, semantic and clinical aspects of aspirin resistance
- Major Bleeding After Catheter-Directed Thrombolysis for Acute Pulmonary Embolism: Derivation and Transferability of the F-HARP Risk Assessment Model
- A standardised ultrasound strategy safely excludes recurrent deep-vein thrombosis without prior imaging.
- Comparative analysis of genes encoding hemostatic proteins in human acute promyelocytic leukemia cells and acute myeloid leukemia cells and their murine counterparts
- Internal lysis of contracted clots is accelerated by fiber alignment and bundling
- Disseminated intravascular coagulopathy in pregnancy: lessons from an international registry of the International Society for Thrombosis and Hemostasis: communication from the SSC of the ISTH
- Joint effect of muscle strength and physical inactivity on risk of incident venous thromboembolism: the Tromsø Study
- Diagnostic utility of the von Willebrand factor collagen-binding activity assay in patients with mild-to-moderate bleeding: results from the Vienna Bleeding Biobank
- Thrombotic rates in individuals with inherited bleeding disorders treated with concentrate or bispecific antibody. Fifteen-year EUHASS data
- KRAS mutation and venous thromboembolism risk in colorectal cancer: a Danish population-based cohort study
- Fragility analysis should complement statistical reporting in thrombosis trials: lessons from reduced-dose direct oral anticoagulants for cancer-associated venous thromboembolism
- Coactivators YAP and TAZ contribute differently to the transcriptional regulation of VWF in endothelial cells
- Thrombin generation in critically ill adults: a systematic review of venous thromboembolism and pharmacological thromboprophylaxis
- Pathogenic mechanisms and novel experimental anti-inflammatory therapies in hemophilic arthropathy
- Heparin management and coagulation in acute aortic dissection surgery: a randomized controlled trial
- Heparin–platelet endothelial aggregation receptor 1 interaction contributes to platelet activation by heparin-induced thrombocytopenia antibodies
- Plasma neutrophil gelatinase-associated lipocalin levels and risk of future incident venous thromboembolism
- Reported items and methods for analysis in diagnostic management studies evaluating venous thromboembolism: a systematic review: Communication from the ISTH SSC Subcommittee on Diagnosis and Prediction in Thrombotic Disease
- Incidence of thrombosis and bleeding in patients with JAK2-positive myeloproliferative neoplasms receiving low-dose aspirin: a systematic review and meta-analysis
- Effect of prothrombin complex concentrate versus frozen plasma on divalent cations and vitamin K-dependent factor function: an ex vivo mechanistic study
- Plasma protein profiles in bleeding disorder of unknown cause
- The Role of Platelet Aggregation and Activation as Biomarkers for Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage